COMPARISON OF PPD AND QUANTIFERON IN DETERMINING LATENT TUBERCULOSIS IN PATIENTS WHO ARE DIRECTED TO TNF ANTAGONISTS. T.ÇAĞATAY ¹ , M.AYDIN ¹ , Z. GÜLBARAN ¹ , R. YILDIZ ¹ , L. PUR ¹ A.GÜL ¹ , M. İNANÇ ² , S. KAMALI ² , K.KÖKSALAN ³ , Z.KILIÇASLAN ²
Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.
T.ÇAĞATAY¹, M.AYDIN¹ , Z. GÜLBARAN¹, R. YILDIZ¹, L. PUR¹ A.GÜL¹, M. İNANÇ ², S. KAMALI², K.KÖKSALAN³, Z.KILIÇASLAN²
İstanbul University, Faculty of Medicine Department of Pulmoner Medicine1
İstanbul University, Faculty of Medicine Department of Rheumatology Medicine2
İstanbul University Molecular TB Epidemiology Laboratory 3
This study is;
A pre-statement for the planned research for evaluation of PPD andQuantiferon-TB-Gold testwhich is an IGRA test to diagnose the latent TB infection in the rheumatismal disease group.